Leuthold Group LLC Takes Position in VanEck Pharmaceutical ETF $PPH

Leuthold Group LLC bought a new stake in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) during the fourth quarter, Holdings Channel reports. The fund bought 8,779 shares of the company’s stock, valued at approximately $906,000.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the business. AlphaCore Capital LLC purchased a new position in shares of VanEck Pharmaceutical ETF during the 4th quarter valued at approximately $31,000. Financial Partners Group Inc purchased a new position in shares of VanEck Pharmaceutical ETF during the 4th quarter valued at approximately $356,000. Truist Financial Corp purchased a new position in shares of VanEck Pharmaceutical ETF during the 4th quarter valued at approximately $230,000. Comerica Bank lifted its position in shares of VanEck Pharmaceutical ETF by 1,490.3% during the 4th quarter. Comerica Bank now owns 986 shares of the company’s stock valued at $102,000 after buying an additional 924 shares in the last quarter. Finally, IMC Chicago LLC purchased a new position in shares of VanEck Pharmaceutical ETF during the 4th quarter valued at approximately $1,707,000.

VanEck Pharmaceutical ETF Price Performance

Shares of NASDAQ:PPH opened at $100.84 on Monday. VanEck Pharmaceutical ETF has a 1 year low of $81.74 and a 1 year high of $112.58. The firm has a market capitalization of $956.97 million, a price-to-earnings ratio of 20.21 and a beta of 0.46. The business’s 50 day moving average price is $102.77 and its 200-day moving average price is $103.23.

VanEck Pharmaceutical ETF Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, April 7th. Shareholders of record on Wednesday, April 1st were issued a $0.8441 dividend. This represents a $3.38 dividend on an annualized basis and a yield of 3.3%. The ex-dividend date was Wednesday, April 1st. This is an increase from VanEck Pharmaceutical ETF’s previous quarterly dividend of $0.31.

About VanEck Pharmaceutical ETF

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.